Genetic testing could help smokers quit

09/26/2007 | M.I.T. Technology Review

Genetic testing showed that people who carry the CYP2B6*6 gene variation are more likely to benefit from the smoking-cessation drug bupropion than those who do not have the gene variation, a new study found. Researchers hope genetic testing could help doctors recommend the best treatments to individuals who want to quit smoking.

View Full Article in:

M.I.T. Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park